Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 44 record(s)

Req # AF-2022-00113

Any emails, documents, letters, meeting notes, video recording between staff at CMHC from 01/01/2018 to 12/31/2022 (including but not limited to David McCulloch) pertaining to Mount Hope Avenue, Dartmouth, Nova Scotia

Organization: Canada Mortgage and Housing Corporation

880 page(s)
July 2023

Req # AF-2023-00005

I would like to receive copies of the four Rapid Housing Initiatives (Cities Stream) applications the Cape Breton Regional Municipality submitted to the CMHC for vetting at some point between March 7 and April 10, 2023. I would like to see the order in which CMHC ranked these proposals and the reasoning behind it. I would also like to see any correspondence between CMHC officials and CBRM officials on this file during this period.

Organization: Canada Mortgage and Housing Corporation

177 page(s)
July 2023

Req # AF-2023-00008

The National Housing Strategy commits a minimum of 25% of investments to projects that benefit women and their children. I have three requests related to this commitment. - I request any briefings or memos on women's housing and/or homelessness provided by the CMHC to elected officials between 2015 and 2022; - Second, I request any progress reports on the 25% of investments commitment; - Finally, I request a list of all programs being counted toward the commitment that 25% of investments be to the benefit of women and their children.”

Organization: Canada Mortgage and Housing Corporation

129 page(s)
July 2023

Req # AF-2023-00016

Latest targets in terms of (a) funding and (b) Units to be built or funded for each phase of all federal National Housing Strategy (NHS) initiatives since its inception specifically for Montreal (Agglomeration Territory). The progress to date, since their inception, in terms of (a) dwellings built or financed, (b) dedicated funding as well as (c) funding requested, for each phase of these same programs under the NHS specifically in Montreal. The above referenced programs include, but are not limited to: (1) Affordable Housing Innovation Fund, (2) Financing the construction of rental housing, (3) Federal Lands Initiative, (4) National Housing Co-Investment Fund, (5) Rapid Housing Initiative, (6) Federal Community Housing Initiative, (7) Sector Transformation Fund, (8) Community Tenant Support Initiative, (9) Single Supplement to the Canada Housing Benefit, (10) Reaching home (11) Participating Mortgage Provider Assistance Fund and (12) First-time homebuyer incentive.

Organization: Canada Mortgage and Housing Corporation

2 page(s)
July 2023

Req # AF-2023-00018

Provide 2022, 2023 CMHC's own assessments of criticisms from the private sector and from public groups and in the media of CMHC 's stands on fixing housing shortages; on making housing more affordable; and on improving infrastructure for housing

Organization: Canada Mortgage and Housing Corporation

0 page(s)
July 2023

Req # AF-2023-00021

Has the $10,000 penalty under subsection 6(1) of the Prohibition on the Purchase of Residential Property by Non-Canadians Act, SC 2022, c 10, s 235 ever been assessed? If so, how many times has it been assessed? Has there been any investigations opened for a potential violation under the Prohibition on the Purchase of Residential Property by Non-Canadians Act, SC 2022, c 10, s 235? If so, how many? Has any special funding been allocated to investigations under the Prohibition on the Purchase of Residential Property by Non-Canadians Act, SC 2022, c 10, s 235. Time frame: 2023-01-01 to 2023-06-28

Organization: Canada Mortgage and Housing Corporation

0 page(s)
July 2023

Req # A-2022-05111

Electronic copies of the following documents. In all cases, cabinet confidences may be excluded and draft versions of documents. In all of the requests below, “draft guidelines” refers to the PMPRB Guidelines that were published for comment on October 6, 2022, or any prior drafts or versions of those 2022 Guidelines (for example, if a draft version was circulated to Health Canada for comment in September 2022, it would be part of the “draft guidelines” for the purpose of this request). • Emails or other communications from Health Canada commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Emails or other communications from the Board members or Board Chair commenting on the draft guidelines, and that were sent between July 1, 2022, and October 6, 2022. • Any training presentations, training manuals, or summaries of the new guidelines prepared for use by the Board Staff, Board, or other governmental departments prepared between July 1, 2022, and October 6, 2022. • Any documents with calculations of how much prices will decrease under the draft guidelines, or under alternative pricing rules, and that were prepared between January 1, 2022, and October 6, 2022 (note the change in date relative to other requests). • Any documents comparing prices or price reductions under the draft guidelines and the old PMPRB Compendium of Guidelines and Procedures. • Any documents, including legal memos, on the compliance of the draft guidelines with legal decisions about the PMPRB, including Alexion Pharmaceuticals Inc. v. Canada (Attorney General), 2021 FCA 157, Merck Canada c Canada, 2022 QCCA 240, and Innovative Medicines Canada v. Canada (Attorney General), 2020 FC 725. • Any documents which discuss how a medicine’s therapeutic class and comparator products will be established under the draft guidelines. • Any documents showing how the Board Staff arrived at the exact pricing tests discussed in paragraph 33-35 of the draft Guidelines. • Any documents which discuss how Board Staff will assess whether a price is excessive *after* an investigation has been opened. For context, the backgrounder which accompanied the draft guidelines suggested that staff will consider “the totality of the circumstances surrounding the price of the medicine, through the lens of the section 85 factors.

Organization: Patented Medicine Prices Review Board Canada

197 page(s)
July 2023

Req # A-2023-025211

With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.

Organization: Patented Medicine Prices Review Board Canada

18 page(s)
July 2023

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023

Req # A-2023-025896

For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?

Organization: Patented Medicine Prices Review Board Canada

588 page(s)
July 2023
Date modified: